Highlights Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 EDT			5-day change	1st Jan Change
3.97 ^HKD	0.00%		-8.10%	-82.12%

04-25	Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	MT
03-27	Jenscare Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%	04-25	MT
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials	03-24	MT
Jenscare Scientific Co., Ltd. Announces Completion of the Enrollment of JensClip for Confirmatory Clinical Trial and One-Month Follow-Up	03-24	CI
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation in Brazil	02-28	CI
Jenscare Scientific’s CEO, CFO Boost Stake in Firm	01-26	MT
Jenscare Scientific Co., Ltd. Completes the First Clinical Implantation of Omniseal	01-02	CI
Jenscare Scientific to Buy Back Shares	12-29	MT
Jenscare Scientific Shareholders Approve of Sale of 22.48% Interest in Congenital Heart Disease Device Maker	12-22	MT
Jenscare Scientific to Divest 22.5% Stake in Medical Device Maker	11-29	MT
Jenscare Scientific Co., Ltd. Announces One-Year Results of the Confirmatory Clinical Trial of the LuX-Valve Transcatheter Tricuspid Valve Replacement System	11-27	CI
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Travel II Results Released At the 2023 TCT in the U.S	23-10-30	CI
Jenscare Shares Surge 16% After China Grants Priority Approval for Aortic Heart Valve System	23-10-29	MT
Jenscare Scientific Co., Ltd. Announces Registration Application of Ken-Valve, the Transcatheter Prosthetic Aortic Heart Valve System Successfully Enters the Priority Approval Process	23-10-29	CI
Jenscare Scientific Co., Ltd. Announces the Results of the Multicenter Clinical Trial of LuX-Valve Plus at the 2023 TCT in the U.S	23-10-18	CI
Jenscare's Stock Drops Despite NMPA Acceptance for Ken-Valve Registration Application	23-10-11	MT
Jenscare Scientific Co., Ltd. Receives Confirmation Letter from the National Medical Products Administration of the People's Republic of China Confirms the Acceptance of the Registration Application for Ken-Valve	23-10-11	CI
Jenscare Scientific Co., Ltd. Announces Lux-Valve Plus Selected for the Expert Panel Scientific Advice Pilot	23-10-10	CI
123,514,232 H Shares of Jenscare Scientific Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-OCT-2023.	23-10-08	CI
252,415,080 Domestic Shares of Jenscare Scientific Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-OCT-2023.	23-10-08	CI
33,161,578 Unlisted Foreign Shares of Jenscare Scientific Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-OCT-2023.	23-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jenscare Scientific Co., Ltd.

Equities

9877

CNE100005KC9

Highlights

Filters